These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17435854)

  • 1. [Corporal fat distribution and lipidic and glicemic profiles of HIV-infected patients].
    Guimarães MM; Greco DB; de O Júnior AR; Penido MG; Machado LJ
    Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):42-51. PubMed ID: 17435854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonographic measurement of intra-abdominal fat thickness in HIV-infected patients treated or not with antiretroviral drugs and its correlation to lipid and glycemic profiles.
    Guimarães MM; de Oliveira AR; Penido MG; Queiroz LC; Goulart EM; Greco DB; Machado LJ
    Ann Nutr Metab; 2007; 51(1):35-41. PubMed ID: 17356264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism.
    Samaras K; Wand H; Law M; Emery S; Cooper DA; Carr A
    Curr HIV Res; 2009 Jul; 7(4):454-61. PubMed ID: 19601783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
    Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
    HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy.
    Estrada V; Serrano-Ríos M; Martínez Larrad MT; Villar NG; González López A; Téllez MJ; Fernández C
    J Acquir Immune Defic Syndr; 2002 Jan; 29(1):32-40. PubMed ID: 11782587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term high-physiological-dose growth hormone reduces intra-abdominal fat in HIV-infected patients with a neutral effect on glucose metabolism.
    Hansen BR; Haugaard SB; Jensen FK; Jensen JE; Andresen L; Iversen J; Andersen O
    HIV Med; 2010 Apr; 11(4):266-75. PubMed ID: 20002779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection.
    Guimarães MM; Greco DB; Figueiredo SM; Fóscolo RB; Oliveira AR; Machado LJ
    Atherosclerosis; 2008 Dec; 201(2):434-9. PubMed ID: 18359028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epicardial adipose tissue is related to carotid intima-media thickness and visceral adiposity in HIV-infected patients with highly active antiretroviral therapy-associated metabolic syndrome.
    Iacobellis G; Sharma AM; Pellicelli AM; Grisorio B; Barbarini G; Barbaro G
    Curr HIV Res; 2007 Mar; 5(2):275-9. PubMed ID: 17346142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study.
    Mercier S; Gueye NF; Cournil A; Fontbonne A; Copin N; Ndiaye I; Dupuy AM; Cames C; Sow PS; Ndoye I; Delaporte E; Simondon KB
    J Acquir Immune Defic Syndr; 2009 Jun; 51(2):224-30. PubMed ID: 19339897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials.
    Sivakumar T; Mechanic O; Fehmie DA; Paul B
    HIV Med; 2011 Sep; 12(8):453-62. PubMed ID: 21265979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fish oil on lipid profile and other metabolic outcomes in HIV-infected patients on antiretroviral therapy: a randomized placebo-controlled trial.
    Oliveira JM; Rondó PH; Yudkin JS; Souza JM; Pereira TN; Catalani AW; Picone CM; Segurado AA
    Int J STD AIDS; 2014 Feb; 25(2):96-104. PubMed ID: 24285599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study.
    Saint-Marc T; Partisani M; Poizot-Martin I; Rouviere O; Bruno F; Avellaneda R; Lang JM; Gastaut JA; Touraine JL
    AIDS; 2000 Jan; 14(1):37-49. PubMed ID: 10714566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance, hepatic lipid and adipose tissue distribution in HIV-infected men.
    He Q; Engelson ES; Ionescu G; Glesby MJ; Albu JB; Kotler DP
    Antivir Ther; 2008; 13(3):423-8. PubMed ID: 18572755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between drug exposure, changes in metabolic parameters and body fat in HIV-infected patients switched to a nucleoside sparing regimen.
    Autar RS; Boyd MA; Wit FW; Ruxrungthams K; Sankote J; Lange J; Cooper DA; Phanuphak P; Burger DM; Reiss P
    Antivir Ther; 2007; 12(8):1265-71. PubMed ID: 18240866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasonographic assessment of lipodystrophy in HIV-1-infected patients.
    Grima PF; Chiavaroli R; Grima P
    Radiol Med; 2009 Feb; 114(1):141-51. PubMed ID: 18956151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution.
    Torriani M; Thomas BJ; Barlow RB; Librizzi J; Dolan S; Grinspoon S
    J Appl Physiol (1985); 2006 Feb; 100(2):609-14. PubMed ID: 16223978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum retinol-binding protein 4 correlates with obesity, insulin resistance, and dyslipidemia in HIV-infected subjects receiving highly active antiretroviral therapy.
    Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Choi JY; Song YG; Lee HC; Kim JM
    Metabolism; 2009 Nov; 58(11):1523-9. PubMed ID: 19501863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasonography and anthropometry for measuring regional body fat in HIV-infected patients.
    Padilla S; Gallego JA; Masiá M; Ardoy F; Hernández I; Gutiérrez F
    Curr HIV Res; 2007 Sep; 5(5):459-66. PubMed ID: 17896965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome.
    Barbaro G
    Curr Pharm Des; 2007; 13(21):2208-13. PubMed ID: 17627554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.